| 000 | 01769 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517222150.0 | ||
| 264 | 0 | _c20190304 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1471-0528 | ||
| 024 | 7 |
_a10.1111/1471-0528.15320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVigil-DeGracia, P | |
| 245 | 0 | 0 |
_aIs there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study. _h[electronic resource] |
| 260 |
_bBJOG : an international journal of obstetrics and gynaecology _cSep 2018 |
||
| 300 |
_a1304-1311 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadministration & dosage |
| 650 | 0 | 4 |
_aDelivery, Obstetric _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnesium Sulfate _xadministration & dosage |
| 650 | 0 | 4 |
_aObstetric Labor Complications _xprevention & control |
| 650 | 0 | 4 |
_aPostpartum Period _xdrug effects |
| 650 | 0 | 4 |
_aPre-Eclampsia _xdrug therapy |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLudmir, J | |
| 700 | 1 | _aNg, J | |
| 700 | 1 | _aReyes-Tejada, O | |
| 700 | 1 | _aNova, C | |
| 700 | 1 | _aBeltré, A | |
| 700 | 1 | _aYuen-Chon, V | |
| 700 | 1 | _aCollantes, J | |
| 700 | 1 | _aTurcios, E | |
| 700 | 1 | _aLewis, R | |
| 700 | 1 | _aCabrera, S | |
| 773 | 0 |
_tBJOG : an international journal of obstetrics and gynaecology _gvol. 125 _gno. 10 _gp. 1304-1311 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1471-0528.15320 _zAvailable from publisher's website |
| 999 |
_c28506851 _d28506851 |
||